backgroundGraphic
Magdalen Scientific
About UsScientific WorkshopsWebinarsOn-demandIndustry PartnershipsContact Us
heroImageheroImage

Independent, Expert-led Scientific Events

We believe in creating opportunities for scientific exchange and best-practice sharing amongst healthcare professionals (HCPs).

We host a variety of scientific workshops and educational webinars each year, focused on the latest clinical updates to advance the medical field, enhance HCP understanding, and improve patient care.

heroImageheroImage

Upcoming Scientific Workshops

Discover our planned workshops for details on agendas and featured faculty

Interested in becoming an industry partner for one of our scientific workshops?

Get in touch
Intercepting Blood Cancers 2025

Intercepting Blood Cancers 2025

13 - 15 March, 2025

Nice, FR

More Info
7th International Workshop on CAR-T

7th International Workshop on CAR-T

11 - 13 April, 2025

Miami, US

More Info
3rd International Workshop on MDS & MPN

3rd International Workshop on MDS & MPN

27 - 29 June, 2025

Lisbon, PT

More Info
7th International Workshop on Acute Leukemias

7th International Workshop on Acute Leukemias

19 - 21 September, 2025

Washington, US

More Info

Interested in becoming an industry partner for one of our scientific workshops?

Get in touch
Intercepting Blood Cancers 2025

Intercepting Blood Cancers 2025

13 - 15 March, 2025

Nice, FR

More Info
7th International Workshop on CAR-T

7th International Workshop on CAR-T

11 - 13 April, 2025

Miami, US

More Info
3rd International Workshop on MDS & MPN

3rd International Workshop on MDS & MPN

27 - 29 June, 2025

Lisbon, PT

More Info
7th International Workshop on Acute Leukemias

7th International Workshop on Acute Leukemias

19 - 21 September, 2025

Washington, US

More Info

Interested in becoming an industry partner for one of our scientific workshops?

Get in touch
Intercepting Blood Cancers 2025

Intercepting Blood Cancers 2025

13 - 15 March, 2025

Nice, FR

More Info
7th International Workshop on CAR-T

7th International Workshop on CAR-T

11 - 13 April, 2025

Miami, US

More Info
3rd International Workshop on MDS & MPN

3rd International Workshop on MDS & MPN

27 - 29 June, 2025

Lisbon, PT

More Info
7th International Workshop on Acute Leukemias

7th International Workshop on Acute Leukemias

19 - 21 September, 2025

Washington, US

More Info
View All Workshops

Upcoming Educational Webinars

Explore the topics of our planned roundup webinars

Interested in supporting one of our educational webinars?

Get in touch
Post-ASH 2024 CLL Highlights

Post-ASH 2024 CLL Highlights

23 January, 2025

11:00–13:00 CST / 17:00–19:00 GMT / 18:00–20:00 CET

More Info
Post-ASH 2024 CML Highlights

Post-ASH 2024 CML Highlights

24 January, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MDS Highlights

Post-ASH 2024 MDS Highlights

28 January, 2025

08:00–10:00 CST / 14:00–16:00 GMT / 15:00–17:00 CET

More Info
Post-ASH 2024 Lymphoma Highlights

Post-ASH 2024 Lymphoma Highlights

30 January, 2025

11:30–13:30 CST / 17:30–19:30 GMT / 18:30–20:30 CET

More Info
Post-ASH 2024 AML Highlights

Post-ASH 2024 AML Highlights

31 January, 2025

09:00–11:30 CST / 15:00–17:30 GMT / 16:00–18:30 CET

More Info
Post-ASH 2024 Multiple Myeloma Highlights

Post-ASH 2024 Multiple Myeloma Highlights

4 February, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MPNs Highlights

Post-ASH 2024 MPNs Highlights

7 February, 2025

12:00–14:00 CST / 18:00–20:00 GMT / 19:00–21:00 CET

More Info

Interested in supporting one of our educational webinars?

Get in touch
Post-ASH 2024 CLL Highlights

Post-ASH 2024 CLL Highlights

23 January, 2025

11:00–13:00 CST / 17:00–19:00 GMT / 18:00–20:00 CET

More Info
Post-ASH 2024 CML Highlights

Post-ASH 2024 CML Highlights

24 January, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MDS Highlights

Post-ASH 2024 MDS Highlights

28 January, 2025

08:00–10:00 CST / 14:00–16:00 GMT / 15:00–17:00 CET

More Info
Post-ASH 2024 Lymphoma Highlights

Post-ASH 2024 Lymphoma Highlights

30 January, 2025

11:30–13:30 CST / 17:30–19:30 GMT / 18:30–20:30 CET

More Info
Post-ASH 2024 AML Highlights

Post-ASH 2024 AML Highlights

31 January, 2025

09:00–11:30 CST / 15:00–17:30 GMT / 16:00–18:30 CET

More Info
Post-ASH 2024 Multiple Myeloma Highlights

Post-ASH 2024 Multiple Myeloma Highlights

4 February, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MPNs Highlights

Post-ASH 2024 MPNs Highlights

7 February, 2025

12:00–14:00 CST / 18:00–20:00 GMT / 19:00–21:00 CET

More Info

Interested in supporting one of our educational webinars?

Get in touch
Post-ASH 2024 CLL Highlights

Post-ASH 2024 CLL Highlights

23 January, 2025

11:00–13:00 CST / 17:00–19:00 GMT / 18:00–20:00 CET

More Info
Post-ASH 2024 CML Highlights

Post-ASH 2024 CML Highlights

24 January, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MDS Highlights

Post-ASH 2024 MDS Highlights

28 January, 2025

08:00–10:00 CST / 14:00–16:00 GMT / 15:00–17:00 CET

More Info
Post-ASH 2024 Lymphoma Highlights

Post-ASH 2024 Lymphoma Highlights

30 January, 2025

11:30–13:30 CST / 17:30–19:30 GMT / 18:30–20:30 CET

More Info
Post-ASH 2024 AML Highlights

Post-ASH 2024 AML Highlights

31 January, 2025

09:00–11:30 CST / 15:00–17:30 GMT / 16:00–18:30 CET

More Info
Post-ASH 2024 Multiple Myeloma Highlights

Post-ASH 2024 Multiple Myeloma Highlights

4 February, 2025

10:00–12:00 CST / 16:00–18:00 GMT / 17:00–19:00 CET

More Info
Post-ASH 2024 MPNs Highlights

Post-ASH 2024 MPNs Highlights

7 February, 2025

12:00–14:00 CST / 18:00–20:00 GMT / 19:00–21:00 CET

More Info
View All Webinars

On-demand Sessions

Browse the panel discussions from our previous scientific workshops

How can we improve efficiency of drug approval for MDS?
How can we improve efficiency of drug approval for MDS?

iwMDS 2022

Miami, US | 24 - 26 June, 2022

View full session
CAR-T in AML: updates & challenges
CAR-T in AML: updates & challenges

iwCAR-T 2023

Scottsdale, US | 14 - 16 April, 2023

View full session
Clonal Hematopoiesis, Early Detection & Potential Therapeutics
Clonal Hematopoiesis, Early Detection & Potential Therapeutics

iwAL 2023

San Diego, US | 25 - 27 August, 2023

View full session
Updates On The Biology And Treatment Of T-Cell Lymphoma
Updates On The Biology And Treatment Of T-Cell Lymphoma

iwNHL 2023

Miami, US | 29 September - 1 October, 2023

View full session
Early Interception In SMM & Novel Agents Being Explored
Early Interception In SMM & Novel Agents Being Explored

IBC Workshop 2024

Lisbon, PT | 14 - 16 March, 2024

View full session
Understanding mechanisms of resistance to targeted therapies in myeloma
View full session
Allo approaches in CAR-T
Allo approaches in CAR-T

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
The future of CAR-T therapy in AML
The future of CAR-T therapy in AML

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
CAR T-cells for autoimmune diseases
CAR T-cells for autoimmune diseases

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
An update on CAR-T in CLL
An update on CAR-T in CLL

iwCAR-T 2024

Miami, US | 19 - 21 April, 2024

View full session
Updates in the diagnosis, classification & risk stratification of MDS
View full session
Inflammation & immune interventions in MDS: targeting STAT, IRAK4 & more
View full session
Updates in HR-MDS therapies: IDH inhibitors, challenges with transplantation, and more
View full session
Novel targets, combinations & treatments in AML: use of OGM, TP53 treatment strategies & ADCs
View full session
Updates on established therapies in AML – Part 2
Updates on established therapies in AML – Part 2

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Updates on established therapies in AML – Part 1
Updates on established therapies in AML – Part 1

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Novel treatments & combinations in AML: mechanisms of resistance to venetoclax & approaching R/R disease
View full session
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
Current data on menin inhibition in AML
View full session
How can we improve efficiency of drug approval for MDS?
How can we improve efficiency of drug approval for MDS?

iwMDS 2022

Miami, US | 24 - 26 June, 2022

View full session
CAR-T in AML: updates & challenges
CAR-T in AML: updates & challenges

iwCAR-T 2023

Scottsdale, US | 14 - 16 April, 2023

View full session
Clonal Hematopoiesis, Early Detection & Potential Therapeutics
Clonal Hematopoiesis, Early Detection & Potential Therapeutics

iwAL 2023

San Diego, US | 25 - 27 August, 2023

View full session
Updates On The Biology And Treatment Of T-Cell Lymphoma
Updates On The Biology And Treatment Of T-Cell Lymphoma

iwNHL 2023

Miami, US | 29 September - 1 October, 2023

View full session
Early Interception In SMM & Novel Agents Being Explored
Early Interception In SMM & Novel Agents Being Explored

IBC Workshop 2024

Lisbon, PT | 14 - 16 March, 2024

View full session
Understanding mechanisms of resistance to targeted therapies in myeloma
View full session
Allo approaches in CAR-T
Allo approaches in CAR-T

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
The future of CAR-T therapy in AML
The future of CAR-T therapy in AML

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
CAR T-cells for autoimmune diseases
CAR T-cells for autoimmune diseases

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
An update on CAR-T in CLL
An update on CAR-T in CLL

iwCAR-T 2024

Miami, US | 19 - 21 April, 2024

View full session
Updates in the diagnosis, classification & risk stratification of MDS
View full session
Inflammation & immune interventions in MDS: targeting STAT, IRAK4 & more
View full session
Updates in HR-MDS therapies: IDH inhibitors, challenges with transplantation, and more
View full session
Novel targets, combinations & treatments in AML: use of OGM, TP53 treatment strategies & ADCs
View full session
Updates on established therapies in AML – Part 2
Updates on established therapies in AML – Part 2

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Updates on established therapies in AML – Part 1
Updates on established therapies in AML – Part 1

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Novel treatments & combinations in AML: mechanisms of resistance to venetoclax & approaching R/R disease
View full session
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
Current data on menin inhibition in AML
View full session
How can we improve efficiency of drug approval for MDS?
How can we improve efficiency of drug approval for MDS?

iwMDS 2022

Miami, US | 24 - 26 June, 2022

View full session
CAR-T in AML: updates & challenges
CAR-T in AML: updates & challenges

iwCAR-T 2023

Scottsdale, US | 14 - 16 April, 2023

View full session
Clonal Hematopoiesis, Early Detection & Potential Therapeutics
Clonal Hematopoiesis, Early Detection & Potential Therapeutics

iwAL 2023

San Diego, US | 25 - 27 August, 2023

View full session
Updates On The Biology And Treatment Of T-Cell Lymphoma
Updates On The Biology And Treatment Of T-Cell Lymphoma

iwNHL 2023

Miami, US | 29 September - 1 October, 2023

View full session
Early Interception In SMM & Novel Agents Being Explored
Early Interception In SMM & Novel Agents Being Explored

IBC Workshop 2024

Lisbon, PT | 14 - 16 March, 2024

View full session
Understanding mechanisms of resistance to targeted therapies in myeloma
View full session
Allo approaches in CAR-T
Allo approaches in CAR-T

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
The future of CAR-T therapy in AML
The future of CAR-T therapy in AML

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
CAR T-cells for autoimmune diseases
CAR T-cells for autoimmune diseases

iwCAR-T 2024

, US | 19 - 21 April, 2024

View full session
An update on CAR-T in CLL
An update on CAR-T in CLL

iwCAR-T 2024

Miami, US | 19 - 21 April, 2024

View full session
Updates in the diagnosis, classification & risk stratification of MDS
View full session
Inflammation & immune interventions in MDS: targeting STAT, IRAK4 & more
View full session
Updates in HR-MDS therapies: IDH inhibitors, challenges with transplantation, and more
View full session
Novel targets, combinations & treatments in AML: use of OGM, TP53 treatment strategies & ADCs
View full session
Updates on established therapies in AML – Part 2
Updates on established therapies in AML – Part 2

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Updates on established therapies in AML – Part 1
Updates on established therapies in AML – Part 1

iwAL 2024

Phoenix, US | 13 - 15 September, 2024

View full session
Novel treatments & combinations in AML: mechanisms of resistance to venetoclax & approaching R/R disease
View full session
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
Current data on menin inhibition in AML
View full session
View All On-demand Sessions

Cookie Settings

We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.

Magdalen Medical PublishingCookie PolicyTerms of UsePrivacy Policy

© 2024 Magdalen Medical Publishing. All rights reserved.

Magdalen Medical Publishing Ltd is a company registered in England and Wales (Company no. 09997585, VAT no. 247098678)

The Oxford Science Park, Magdalen Centre, Oxford, OX4 4GA